DROSPIRENONE

Drospirenone Impurities: Process, Degradation, Chiral Impurities / Drospirenone Related Compounds / Reference Standards

Drospirenone is a synthetic progestin used primarily in combination oral contraceptives and hormone replacement therapies. It exhibits anti-mineralocorticoid and anti-androgenic properties, making it a unique molecule among steroidal APIs.

SynThink Research Chemicals offers a comprehensive suite of Drospirenone impurities and pharmaceutical reference standards to support analytical, regulatory, and formulation development workflows. Our catalog includes process-related impurities, degradation products, chiral impurities (Drospirenone contains chiral centers), genotoxic impurities, regioisomeric variants, and potential impurities—all critical for ANDA/NDA submissions, quality control, stability studies, and toxicity assessments of Drospirenone and its formulations.

These impurity standards are also essential for HPLC method development and validation, ensuring robust and reproducible analytical performance. SynThink’s in-stock Drospirenone-related compounds are typically shipped within 48 hours, and we offer custom synthesis for novel or unavailable impurities with a responsive turnaround time of 3–4 weeks.

Each product is delivered with a Certificate of Analysis (CoA), 1H NMR, Mass, and HPLC purity data, with RT and RRT available upon request. Our experienced Ph.D./M.Sc. chemists work closely with your technical team to understand project goals and deliver scientifically sound solutions. SynThink stands as a strategic partner, offering flexible, cost-effective, and expert-driven support for your Drospirenone development programs.